Skip to main content

Table 5 Summary of adverse events during post-op

From: Impact of intra-operative cell salvage on blood coagulation in high-bleeding-risk patients undergoing cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial

Variable Group CS (n = 53) Group C (n = 50) P value
Excessive bleeding 17 (32.08) 8 (16.00) 0.038
Resternotomy 3 (5.66) 2 (4.00) 1.000
Cardiovascular failure 6 (11.32) 7 (14.00) 0.682
Severe arrhythmias requiring treatment 4 (7.55) 3 (6.00) 1.000
Myocardial infarction 1 (1.89) 4 (8.00) 0.196
Infection 7 (13.21) 6 (12.00) 0.948
 Wound 3 (5.66) 2 (4.00) 1.000
 Others 4 (7.55) 4 (8.00) 1.000
Renal failure 5 (9.43) 4 (8.00) 1.000
Respiratory failure 3 (5.66) 2 (4.00) 1.000
Epileptic syndrome 1 (1.89) 1 (2.00) 1.000
Cognitive decline 0 (0.00) 3 (6.00) 0.111
Death 0 (0.00) 0 (0.00)  
  1. Data are presented as number (percentage)